Role of Chronic Hyperglycemia in the Pathogenesis of Coronary Microvascular Dysfunction in Diabetes
Overview
Affiliations
Objectives: We sought to determine the differences in coronary microvascular function between patients with type 1 (insulin-deficient) and type 2 (insulin-resistant) diabetes mellitus (DM).
Background: Coronary vascular function is impaired in patients with DM. However, it is unclear whether the type and/or severity of this vascular dysfunction are similar in patients with type 1 and type 2 DM.
Methods: We studied 35 young subjects with DM (18 with type 1 and 17 with type 2), who were free of overt cardiovascular complications, and 11 age-matched healthy controls. Positron emission tomography imaging was used to measure myocardial blood flow (MBF) at rest, during adenosine-induced hyperemia (reflecting primarily endothelium-independent vasodilation), and in response to cold pressor test (CPT) (reflecting primarily endothelium-dependent vasodilation).
Results: The two groups of diabetics were similar with respect to age and glycemic control. The duration of diabetes was longer and high-density lipoprotein cholesterol levels were higher in type 1 than in type 2 diabetics. Basal MBF was similar in the three groups studied. The increase (from baseline) in MBF with adenosine was similar in the subjects with type 1 (161 +/- 18%) and type 2 (185 +/- 19%) DM, but lower than in the controls (351 +/- 43%) (p < 0.001 for the comparison with both groups of diabetics). Similarly, the increase in MBF during the CPT was comparable in the subjects with type 1 (23 +/- 4%) and type 2 (19 +/- 3%) DM, but lower compared with the controls (66 +/- 12%) (p < 0.0001 for the comparison with both groups of diabetics). These differences persisted after adjusting for the duration of diabetes, insulin treatment, metabolic abnormalities, and autonomic neuropathy.
Conclusions: These results demonstrate markedly reduced and similar endothelium-dependent and -independent coronary vasodilator function in subjects with both type 1 and type 2 DM. These results suggest a key role of chronic hyperglycemia in the pathogenesis of vascular dysfunction in diabetes.
Tomizawa N, Ozu H, Kamio S, Fujimoto S, Nozaki Y, Fan R Int J Cardiovasc Imaging. 2025; .
PMID: 39992566 DOI: 10.1007/s10554-025-03361-6.
A Saudi Heart Association Position Statement on Cardiovascular Diseases and Diabetes Mellitus.
AlHabeeb W, Elasfar A, Kinsara A, Aljizeeri A, Jelaidan I, Alghalayini K J Saudi Heart Assoc. 2025; 36(4):385-407.
PMID: 39822337 PMC: 11737320. DOI: 10.37616/2212-5043.1407.
Diagnostic Value of Magnetocardiography to Detect Abnormal Myocardial Perfusion: A Pilot Study.
Zhang H, Ma Z, Mi H, Jiao J, Dong W, Yang S Rev Cardiovasc Med. 2024; 25(10):379.
PMID: 39484136 PMC: 11522775. DOI: 10.31083/j.rcm2510379.
Novel diagnostic approaches and management of coronary microvascular dysfunction.
Pompei G, Ganzorig N, Kotanidis C, Alkhalil M, Collet C, Sinha A Am J Prev Cardiol. 2024; 19:100712.
PMID: 39161975 PMC: 11332818. DOI: 10.1016/j.ajpc.2024.100712.
Endothelial microRNAs in INOCA patients with diabetes mellitus.
Ferrone M, Ciccarelli M, Varzideh F, Kansakar U, Guerra G, Cerasuolo F Cardiovasc Diabetol. 2024; 23(1):268.
PMID: 39039512 PMC: 11265336. DOI: 10.1186/s12933-024-02331-x.